Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum

Neurosci Lett. 1993 Apr 2;152(1-2):113-6. doi: 10.1016/0304-3940(93)90496-8.

Abstract

Rats were treated with deprenyl for 3 weeks. Afterwards, slices of the corpus striatum were incubated with 1-methyl-4-phenylpyridinium ion (MPP+). Concentrations of dopamine and its metabolite concentrations were assayed. The effect of MPP+ in animals treated with deprenyl was smaller than in controls, indicating that deprenyl protects against MPP+. We also measured superoxide dismutase (SOD) and catalase activities and carbonyl group content of the proteins. Both activities increased in deprenyl-treated rats, and the amount of carbonyl groups was unchanged. These results suggest that the protective effect of deprenyl is independent of the monoamine oxidase-B inhibitor and of the induction of SOD and catalase activities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / antagonists & inhibitors*
  • 1-Methyl-4-phenylpyridinium / toxicity
  • Animals
  • Catalase / metabolism
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Dopamine / metabolism
  • Male
  • Monoamine Oxidase / metabolism
  • NAD(P)H Dehydrogenase (Quinone) / antagonists & inhibitors
  • Nerve Tissue Proteins / metabolism*
  • Oxidation-Reduction
  • Rats
  • Rats, Wistar
  • Selegiline / pharmacology
  • Selegiline / therapeutic use*
  • Superoxide Dismutase / metabolism

Substances

  • Nerve Tissue Proteins
  • Selegiline
  • Catalase
  • Superoxide Dismutase
  • Monoamine Oxidase
  • NAD(P)H Dehydrogenase (Quinone)
  • 1-Methyl-4-phenylpyridinium
  • Dopamine